Journal Information
Vol. 53. Issue 3.
Pages 249-252 (1 September 2000)
Share
Share
Download PDF
More article options
Vol. 53. Issue 3.
Pages 249-252 (1 September 2000)
Full text access
Estudio inmunohematológico de la enfermedad hemolítica ABO
Immunohematologic study of ABO hemolytic disease
Visits
18941
J. Cid Vidal*, E. Elies Fibla
Centre de Transfusió i Banc de Teixits. Tarragona
Related content
An Pediatr (Barc). 2001;54:7710.1016/S1695-4033(01)78654-7
This item has received
Article information
Objetivo

La enfermedad hemolítica ABO puede manifestarse cuando existe incompatibilidad de grupo ABO entre la madre y el hijo. El objetivo del presente estudio fue analizar la incompatibilidad serológica ABO presente en nuestro centro, comparar 2 técnicas immunohematológicas para su diagnóstico serológico y evaluar la repercusión de la incompatibilidad ABO en el hematócrito de la sangre de cordón umbilical.

Métodos

Se realizó el grupo ABO y Rh(D) en 881 muestras de sangre materna y de sangre de cordón. Con esta última se realizó la prueba de la antiglobulina directa (PAD), el eluido y el microhematócrito.

Resultados

La incompatibilidad ABO se dio en 134 (15,3%) casos. Ésta se detectó con la PAD y el eluido en un 31,6 y 68,4% de los casos estudiados, respectivamente (p = 0,001). El grupo con incompatibilidad ABO presentó unas cifras de hematócrito inferiores al grupo sin incompatibilidad, con una diferencia estadísticamente significativa (44 ± 7,8% frente a 46,5 ± 6,5%; p = 0,029).

Conclusiones

Aunque la enfermedad hemolítica ABO clínicamente significativa es rara, la incompatibilidad ABO se detecta con las técnicas serológicas comúnmente utilizadas y es causa de cierto grado de hemólisis en el recién nacido.

Palabras clave:
Enfermedad hemolítica ABO
Eluido
Prueba de la antiglobulina directa
Hematócrito
Ojective

ABO-hemolytic disease occurs when ABO-incompatibility is present between the mother and the fetus. The objective of the present study was to analyze ABO-hemolytic disease in our center, to compare two serologic tests to diagnose it and to evaluate hematocrit values in cord blood samples.

Methods

ABO and Rh(D) group was found in 881 blood samples. Umbilical cord blood samples were obtained and direct antiglobulin test (DAT), eluate and microhematocrit were performed.

Results

ABO-incompatibility was found in 134 (15.3%) cases. DAT was positive in 31.6% of patients studied with ABOincompatibility and the eluate identified the antibody in 68.4% of studied patients (p = 0.001). Hematocrit values were lower in the group with ABO-incompatibility than in the ABO-compatible group (44 ± 7.8% vs. 46.5 ± 6.5%; p = 0.029).

Conclusions

Although severe ABO hemolytic disease is rare, ABO incompatibility is detected with current serologic tests and it causes a certain degree of hemolysis in newborn infants.

Keywords:
ABO hemolytic disease
Eluate
Direct antiglobulin test
Hematocrit
Full text is only aviable in PDF
Bibliografía
[1.]
V. Vengelen-Tyler.
Technical manual, 12.a,
[2.]
P.L. Mollison, C.P. Engelfriet, M. Contreras.
Blood transfusion in clinical medicine, 10.a,
[3.]
J.R. Melvin, J.S. Sanfillipo, K.W. Dobra, L.S. Cronholm, A. Maldonado.
An improved method of acid elution and its application in obstetric and immunohematology.
Am J Obstet Gynecol, 141 (1981), pp. 25-29
[4.]
A. Álvarez, S. Rives, S. Montoto, C. Sanz, A. Pereira.
Relative sensitivity of direct antiglobulin test, antibody’s elution and flow cytometry in the serologic diagnosis of immunehemolytic transfusion reactions.
Transfusion, 39 (1999), pp. 59
[5.]
J. Sentis, H. Pardell, E. Cobo, J. Canela.
Bioestadística, 2.a, Masson, (1995),
[6.]
W.M. Watkins, P. Greenwell, A.D. Yates.
The genetic and enzymatic regulation of the synthesis of the A and B determinants in the ABO blood group system.
Immunol Commun, 10 (1981), pp. 83-100
[7.]
J. McCullough.
McGraw Hill, (1998),
[8.]
N.N. Kirkman.
Further evidence for a racial difference in frequency of ABO hemolytic disease.
J Pediatr, 90 (1977), pp. 717-720
[9.]
L. Cariani, E.L. Romano, N. Martínez, R. Montano, G. Suárez, I. Ruiz, et al.
ABO-haemolytic disease of the newborn (ABO-HDN):factors influencing its severity and incidence in Venezuela.
J Trop Pediatr, 41 (1995), pp. 14-21
[10.]
S.T. Al-Jawad, P. Keenan, S. Kholeif.
Incidence of ABO haemolytic disease in a mixed Arab population.
Saudi Med J, 7 (1985), pp. 41-45
[11.]
D. Voak, C.C. Bowley.
A detailed serological study on the prediction and diagnosis of ABO haemolytic disease of the newborn (ABO-HDN).
Vox Sang, 17 (1969), pp. 321-326
[12.]
D. Voak, M.A. Williams.
An explanation of the failure of the direct antiglobulin test to detect erythrocyte sensitisation in ABO haemolytic disease of the newborn and observations on pinocytosis of Ig anti-A antibodies in infant (cord) red cells.
Brit J Haematol, 20 (1971), pp. 9-16
[13.]
A. Álvarez, S. Rives, S. Montoto, C. Sanz, A. Pereira.
Relative sensitivity of direct antiglobulin test, antibody’s elution and flow cytometry in the serologic diagnosis of immune hemolytic transfusion reactions.
Haematologica, 85 (2000), pp. 186-188
[14.]
R. Rosenfield, G. Ohno.
A-B hemolytic disease of the newborn.
Rev Hémat, 10 (1955), pp. 231-236
[15.]
C.G. Falterman, J. Richardson.
Transfusion reaction due to unrecognised ABO haemolytic disease of the newborn infant.
J Pediatr, 97 (1980), pp. 812-814
Copyright © 2000. Asociación Española de Pediatría
Download PDF
Idiomas
Anales de Pediatría (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?